Stock Market update: Sun Pharma stocks hit 52-weeks high, Cipla & Dr. Reddy witness loss

Sun Pharmaceutical Industries Limited is the largest Indian multinational company headquartered in Mumbai.

On January 3, 2022, stocks of a pharmaceuticals company, Sun Pharmaceutical Industries Limited hit a 52-weeks high at 860.06 per unit. Whereas, last month in December 2021, the company’s share price was at Rs 751.80 per unit.

On the other hand, pharmaceutical company Cipla has witnessed a loss in its share price. Cipla’s share price hit Rs 952.75 on 30 December 2021, whereas, it went down to Rs 929.25 on 3 January 2022. The annual net income of the company Cipla as of September 2021 is estimated to be around Rs 5580.47 crores.

Dr. Reddy’s Laboratories has also seen a considerable decline in the share price. Dr. Reddy’s Laboratories share price went down to Rs 4877.45 (3 January,22) from Rs 4904.70 per unit (30 December,21)

Sun Pharmaceutical Industries Limited is the largest Indian multinational company headquartered in Mumbai. The company also produces a wide range of products including tablets, injectables, ointments, creams and liquids. As of March 2021, the company’s yearly Net Sales Turnover is estimated to be around INR 12953.43 crores. Whereas, in March 2020, it was INR 14042.85 crores.

 

 

Subscribe to our newsletter
Subscribe to our newsletter
Sign up here to get the latest news delivered directly to your inbox.
You can unsubscribe at any time